Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

PHRM 865 > E2 Erdman FQs > Flashcards

E2 Erdman FQs Flashcards

1
Q

all FQs today are structural derivatives of ?

A

nalidixic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what did the “fluorinated” quinolones do that made them a major therapeutic advance

A

improved PK properties, gave better oral absorption, tissue penetration, longer half lives

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are the 4 FQs for us to know

A

Ciprofloxacin
Levofloxacin
Moxifloxacin
Delafloxacin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

FQ MOA

A

inhibit DNA synthesis by inhibiting bacterial topoisomerases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

the FQs target bacterial DNA ______ and topoisomerase ___

A

DNA gyrase (topo II)
IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

FQs form ______ complex with DNA and DNA gyrase which blocks ______ _________

A

stable
dna replication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

removes excess positive supercoiling in DNA helix
A. topo II
B. topo IV

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

essential for separation of interlinked daughter DNA molecules
A. topo II
B. topo IV

A

B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Primary target in GN bacteria:
A. Topo II
B. Topo IV

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Primary target for many GP bacteria:
A. Topo II
B. Topo IV

A

B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

T or F:
FQs are time dependent with bactericidal activity

A

false, conc dependent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

4 mechs of resistance for FQs

A
  • altered binding sites
  • expression of active efflux
  • altered cell wall permeability
  • cross-resistance between FQs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

FQ SoA:
GP aerobes

A
  • group and viridans streptococci (limited)
  • Streptococcus pneumoniae (including PRSP)**
  • enterococcus spp (limited)
  • staphylococcus aureus (MRSA) (only dela, ssti) ***
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Has poor activity against GP bacteria:
A. Delafloxacin
B. Levofloxacin
C. Ciprofloxacin
D. Moxifloxacin

A

C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

treat MRSA:
A. Delafloxacin
B. Levofloxacin
C. Ciprofloxacin
D. Moxifloxacin

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

does not cover streptococcus pneumoniae (including PRSP)
A. Delafloxacin
B. Levofloxacin
C. Ciprofloxacin
D. Moxifloxacin

A

C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

FQ SoA:
GN aerobes
(highlighted in slides and doc)

A
  • enterobacteriaceae
  • pseudomonas aeruginosa ** (not moxi tho)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

does not cover pseudomonas aeruginosa
A. Delafloxacin
B. Levofloxacin
C. Ciprofloxacin
D. Moxifloxacin

A

D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

best option for pseudomonas aeruginosa
A. Delafloxacin
B. Levofloxacin
C. Ciprofloxacin
D. Moxifloxacin

A

C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

FQ SoA:
anaerobes

A

moxi has limited activity against bacteroides spp

21
Q

FQ SoA:
atypical bacteria

A

ALL FQs have excellent activity against atypicals:
- Legionella
- Chlamydophila and Chlamydia spp
- Mycoplasma spp
- ureaplasma urealyticum
******* for all

22
Q

out of all atypical bacteria which are FQs “extremely” active against

A

legionella

23
Q

FQ SoA:
“other organisms” (2)

A

mycobacterium tuberculosis
Bacillus anthracis

24
Q

Correlates with efficacy for FQs:
A. Cmax/MIC
B. AUC/MIC
C. MIC/AUC
D. Cmax x MIC

25
Q

what is PAE

A

post-antibiotic effect

26
Q

T or F:
FQs display a PAE against GN and GP bacteria

27
Q

least oral bioavailability:
A. Delafloxacin
B. Levofloxacin
C. Ciprofloxacin
D. Moxifloxacin

28
Q

T or F:
FQs have a lower conc-time profile than B-lactams

A

false, higher

29
Q

NOT good for infections of urinary tract and prostate:
A. Delafloxacin
B. Levofloxacin
C. Ciprofloxacin
D. Moxifloxacin

30
Q

T or F:
FQs have excellent CSF penetration

A

false, minimal

31
Q

5 highlighted body locations FQs distribute to

A
  • lung
  • bone
  • prostate
  • sputum
  • bronchial mucosa
32
Q

How are the FQs eliminated?

A

renally, except for moxi

33
Q

Hepatically eliminated:
A. Delafloxacin
B. Levofloxacin
C. Ciprofloxacin
D. Moxifloxacin

34
Q

Which FQs are removed during hemodialysis?

35
Q

which of the following can be used for upper RTIs?
A. Delafloxacin
B. Levofloxacin
C. Ciprofloxacin
D. Moxifloxacin

36
Q

which of the following are used for lower RTIs
A. Delafloxacin
B. Levofloxacin
C. Ciprofloxacin
D. Moxifloxacin

37
Q

which of the following are used for nosocomial pneumonia
A. Delafloxacin
B. Levofloxacin
C. Ciprofloxacin
D. Moxifloxacin

38
Q

which of the following is used in bacterial exacerbations in cystic fibrosis
A. Delafloxacin
B. Levofloxacin
C. Ciprofloxacin
D. Moxifloxacin

39
Q

Which of the following are used for UTIs?
A. Delafloxacin
B. Levofloxacin
C. Ciprofloxacin
D. Moxifloxacin

40
Q

which of the following is used for skin and skin structure infections
A. Delafloxacin
B. Levofloxacin
C. Ciprofloxacin
D. Moxifloxacin

41
Q

which of the following is used for chronic bacterial prostatitis
A. Delafloxacin
B. Levofloxacin
C. Ciprofloxacin
D. Moxifloxacin

42
Q

FQ AEs:
neurologic
(highlighted)

A

peripheral neuropathy (a new box warning cool)

43
Q

FQ AEs:
hepatotoxicity

A
  • LFT elevation
  • moxi has been associated with liver failure
44
Q

FQ AEs:
cardiac

A

prolongation of QT interval

45
Q

which of the following should be used with caution in pts with hypokalemia, taking antiarrhythmics, or a preexisting QTc prolongation
A. Delafloxacin
B. Levofloxacin
C. Ciprofloxacin
D. Moxifloxacin

46
Q

FQ AEs:
articular cartilage damage leads to a CI in what 2 populations of patients

A

pediatric
pregnant/breastfeeding women

47
Q

which of the following can cause tendonitis and tendon rupture
A. Delafloxacin
B. Levofloxacin
C. Ciprofloxacin
D. Moxifloxacin

48
Q

notable drug interactions for ALL FQs:

A
  • divalent and trivalent cations (this is for ALL PO FQs), ZICAM, antacids, sucralfate, enteral feeds
  • warfarin -> idiosyncratic, also all FQs
49
Q

which of the following has drug interactions with cyclosporine and theophylline
A. Delafloxacin
B. Levofloxacin
C. Ciprofloxacin
D. Moxifloxacin

PHRM 865 (16 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions